Results

Total Results: 369 records

Showing results for "investment".

301. Disposition of Comments_Technical Brief 52: Pediatric Quality Measures Program 3.0: An Evidence Map of Measures for Vision, Hearing, and Developmental Screening and Followup (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-disposition-comments.pdf
     April 07, 2025 - Provide Financial Transparency and Data: Include an appendix outlining federal and state investments

302. Medication-Therapy-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
     November 01, 2014 - Given the widespread implementation of MTM and urgent need for actionable information, optimal investments

303. Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
     December 16, 2014 - political atmosphere around this disease coupled with its high incidence, strong advocacy base, corporate investments

304. Disposition of Comments for Screening for Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_disposition-comments.pdf
     April 01, 2012 - on Screening for Glaucoma AHRQ Review 10/12/2011 4 Research, Independence for Older Americans: An Investment

305. Disposition of Comments Report for The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
     September 29, 2014 - One policy implication not explicitly stated is the need for investment in research funding.

306. Disposition of Comments Report for CER 207 on PTSD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-207-ptsd-disposition-comments.pdf
     May 17, 2018 - Disposition of Comments Report for CER 207 on PTSD Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Psychological and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD): A Systematic Review Update Draft review available for public comment from No…

307. Abnormal-Uterine-Bleeding Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
     March 01, 2013 - 1 Comparative Effectiveness Review Number 96 Primary Care Management of Abnormal Uterine Bleeding Executive Summary Background Abnormal uterine bleeding (AUB) is among the most common gynecologic complaints of reproductive-age women in ambulatory care settings. It is estimated to affect 11 to 13 percent of…

308. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
     December 01, 2011 - Layout 1 Background Coronary stents and adjunctive pharmacologic agents—including glycoprotein IIb/IIIa receptor inhibitors and thienopyridines—have improved the efficacy of percutaneous coronary intervention (PCI).1,2 However, dislodgement of atherothrombotic material from coronary lesions during PCI can result in …

309. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
     March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…

310. REQUEST FOR TASK ORDER (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
     April 01, 2010 - REQUEST FOR TASK ORDER The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of AHRQ's Effective Health Care Program. It is a collaborative network of research centers that support the rapid development of new scientific information and analytic tools. The DEcIDE network…

311. ASSESSING THE QUALITY OF INCLUDED STUDIES (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
     June 02, 2011 - ASSESSING THE QUALITY OF INCLUDED STUDIES 6/09/11 1 Assessing the Risk of Bias of Individual Studies when Comparing Medical Interventions Introduction In this document, we update existing AHRQ guidance for systematic reviews on assessment of risk of bias of individual studies. As with other AHRQ method…

312. Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin - Executive Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-199-skin-cancer.pdf
     December 01, 2017 - Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin - Executive Summary Comparative Effectiveness Review Number 199 Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin Evidence Summary Introduction Skin cancers, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC),…

313. FRN 30: Outpatient Case Management for Adults With Medical Illnesses and Complex Care Needs: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/case-management-future_research.pdf
     June 01, 2015 - members with primary care provider Cost • All program costs • The cost outcome • Return on investment

314. Disposition of Comments for Technical Brief 28 MAT Models (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
     December 06, 2016 - Expanded federal investment to support prevention and care services for people who use drugs is paramount

315. Disposition of Comments for CER 160 Binge Eating Disorder (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
     December 09, 2015 - The results clearly suggest the need for new investment in BED and LOC research.

316. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
     February 01, 2013 - Given the clinical and economic importance of treating CAD in women, the ongoing investment in CAD research

317. A Prospective Comparison of Evidence Synthesis Search Strategies Developed With and Without Text-Mining Tools (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-results-search-strategies-developed-with-without-text-mining-tools.pdf
     March 01, 2021 - A Prospective Comparison of Evidence Synthesis Search Strategies Developed With and Without Text-Mining Tools Methods Research Report A Prospective Comparison of Evidence Synthesis Search Strategies Developed With and Without Text- Mining Tools Methods Rese…

318. Making Healthcare Safer IV Rapid Review: Patient Monitoring Systems To Prevent Failure To Rescue (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
     December 01, 2024 - • Danesh et al. (2019) reported that organizational resources, specifically the organization’s investment

319. Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
     October 12, 2016 - Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/ ?pageaction=displayproduct&productid=2320 Published Online: October 12, 2016 Evidence Report/Technology Assessment Disposition of Comments Report R…

320. Glaucoma-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
     April 01, 2012 - 1 Comparative Effectiveness Review Number 60 Treatment for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment and blindness both in the United States and worldwide. It is estimated to affect 60.5 million people worldwide.1 Glaucoma is defined as…